Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Other neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 78Carcinoma, Non-Small-Cell Lung 16Oropharyngeal Neoplasms 13Mouth Neoplasms 11Carcinoma, Squamous Cell 11Thyroid Carcinoma, Anaplastic 10Neoplasm Metastasis 10Thyroid Neoplasms 9Salivary Gland Neoplasms 9Recurrence 9Hypopharyngeal Neoplasms 9Carcinoma 9Neoplasms 8Nasopharyngeal Neoplasms 8Nasopharyngeal Carcinoma 8Melanoma 8Laryngeal Neoplasms 8Ovarian Neoplasms 7Lung Neoplasms 7Breast Neoplasms 7Endometrial Neoplasms 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Esophageal Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma, Ovarian Epithelial 4Tongue Neoplasms 3

Interventions

Cetuximab 16Cisplatin 15Radiotherapy, Intensity-Modulated 10Radiotherapy 6Docetaxel 6Erlotinib Hydrochloride 5Fluorouracil 4Everolimus 4Carboplatin 4Sorafenib 3Radiation 3Paclitaxel 3Fluorodeoxyglucose F18 3Chemotherapy, Adjuvant 3Biopsy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Platinum 2Photochemotherapy 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Drug Therapy 2Celecoxib 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tongue Neoplasms × Paclitaxel × Head & Neck × Clear all
NCT01084083 2023-06-28

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
90 enrolled 7 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

NCT01316757 2018-02-26

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Fox Chase Cancer Center

Phase 2 Completed
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01333085 2016-02-10

CAPRA

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1/2 Completed
49 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡